Cargando…

Diagnostic parameters of modified two-tier testing in European patients with early Lyme disease

Modified two-tier testing (MTTT) for Lyme borreliosis (i.e. confirmation with an EIA instead of an immunoblot) has been shown to have improved sensitivity compared with standard two-tier testing (STTT) in samples from American patients, without losing specificity. The current study assesses the sens...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baarsma, ME, Schellekens, JFP, Meijer, BC, Brandenburg, AH, Souilljee, T., Hofhuis, A, Hovius, JW, van Dam, AP
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561539/ https://www.ncbi.nlm.nih.gov/pubmed/32632699 http://dx.doi.org/10.1007/s10096-020-03946-0

Ejemplares similares

The Initial QuantiFERON-Lyme Prototype is Unsuitable for European Patients
por: Baarsma, M E, et al.
Publicado: (2021)

Knowing the entire story – a focus group study on patient experiences with chronic Lyme-associated symptoms (chronic Lyme disease)
por: Baarsma, M. E., et al.
Publicado: (2022)

Control of Lyme borreliosis and other Ixodes ricinus-borne diseases
por: Sprong, Hein, et al.
Publicado: (2018)

Opinion: Methodological Shortcomings in the Study on a Prophage-based PCR Test for Lyme Borreliosis
por: van de Schoor, Freek R., et al.
Publicado: (2021)

Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease
por: Khan, Farhan, et al.
Publicado: (2022)

286. Rapid, One-Tier Diagnosis for Lyme Arthritis
por: Sharon, Bazak, et al.
Publicado: (2018)

Single-tier point-of-care serodiagnosis of Lyme disease
por: Ghosh, Rajesh, et al.
Publicado: (2023)

Validation of cellular tests for Lyme borreliosis (VICTORY) study
por: van de Schoor, F. R., et al.
Publicado: (2019)

Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area
por: van den Wijngaard, Cees C, et al.
Publicado: (2017)

The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis
por: Leeflang, M. M. G., et al.
Publicado: (2016)

861. Development and Clinical Validation of a Custom Modified Two-Tier Testing Algorithm for Serodiagnosis of Lyme Disease
por: Gaylord, Michelle A, et al.
Publicado: (2023)

General practitioner reported incidence of Lyme carditis in the Netherlands
por: Hofhuis, A., et al.
Publicado: (2015)

An ultra-high-density protein microarray for high throughput single-tier serological detection of Lyme disease
por: Jayaraman, Vasanth, et al.
Publicado: (2020)

Physician reported incidence of early and late Lyme borreliosis
por: Hofhuis, Agnetha, et al.
Publicado: (2015)

Erratum to: Physician reported incidence of early and late Lyme borreliosis
por: Hofhuis, Agnetha, et al.
Publicado: (2015)

The Performance of Nine Commercial Serological Screening Assays for the Diagnosis of Lyme Borreliosis: a Multicenter Modified Two-Gate Design Study
por: Hoeve-Bakker, B. J. A., et al.
Publicado: (2022)

An intervention in general practice to improve the management of Lyme borreliosis in Denmark
por: Knudtzen, Fredrikke Christie, et al.
Publicado: (2022)

Digital disparities among healthcare workers in typing speed between generations, genders, and medical specialties: cross sectional study
por: Schuurman, Alex R, et al.
Publicado: (2022)

ELISPOT assays and their diagnostic potential in Lyme disease and Lyme neuroborreliosis
por: Ettischer‐Schmid, N., et al.
Publicado: (2020)

Role of Tier-0, Tier-1 and Tier-2 Regional Centers in CMS DC04
por: Barrass, T, et al.
Publicado: (2004)

Epidemiology of Lyme Disease in a Highly Endemic European Zone
por: Petrulionienė, Agnė, et al.
Publicado: (2020)

Improved Serodiagnostic Performance for Lyme Disease by Use of Two Recombinant Proteins in Enzyme-Linked Immunosorbent Assay Compared to Standardized Two-Tier Testing
por: Bradshaw, Gary L., et al.
Publicado: (2017)

The devil in the tiers
por: Feldman, Robin
Publicado: (2021)

A tier-upon-tier march towards the impact factor
por: Martelletti, Paolo
Publicado: (2008)

Example of shared ATLAS Tier2 and Tier3 facilities
por: Gonzalez de la Hoz, S, et al.
Publicado: (2012)

Arthritis and Diagnostics in Lyme Disease
por: Quintero, Javier A., et al.
Publicado: (2021)

Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect)
por: Vrijmoeth, Hedwig D., et al.
Publicado: (2019)

Atlas operation in the GridKa Tier1/Tier2 Cloud
por: Nderitu, S, et al.
Publicado: (2010)

Atlas operation in the GridKa Tier1/Tier2 Cloud
por: Nderitu, S, et al.
Publicado: (2011)

Exporting Raw/ESD data from Tier-0 $\to$ Tier-1s
por: Bärring, O
Publicado: (2004)

Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions
por: Fahed, Akl C., et al.
Publicado: (2020)

Revue tiers monde.
Publicado: (1960)

Atlas Tier 3
por: Benjamin, D
Publicado: (2010)

Tiered Storage For LHC
por: Yang, Wei, et al.
Publicado: (2012)

Investigating BB0405 as a novel Borrelia afzelii vaccination candidate in Lyme borreliosis
por: Klouwens, M. J., et al.
Publicado: (2021)

LCG Service Challenge 3 at the Spanish Tier-1 and Tier-2 sites
por: Hernández, Jose M, et al.
Publicado: (2006)

Direct Diagnostic Tests for Lyme Disease
por: Schutzer, Steven E, et al.
Publicado: (2019)

Personalising cardiovascular network models in pregnancy: A two‐tiered parameter estimation approach
por: Carson, Jason, et al.
Publicado: (2020)

Neurofilament Light in Cerebrospinal Fluid is Associated With Disease Staging in European Lyme Neuroborreliosis
por: Mens, Helene, et al.
Publicado: (2022)

Protective Immunity and New Vaccines for Lyme Disease
por: Gomes-Solecki, Maria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ms7orbv42gbv10comvmbfngqhs